Fenwick & West LLP advised Twilio on the deal. Twilio (NYSE:TWLO), the leading cloud communications platform, announced that it has entered into a definitive agreement to...
You must be a Standard 1 Year member to access this content.
McCarthy Tétrault advised Vena in connection with the financing. On April 27, 2021, Vena announced it has raised C$300 million in Series C funding. The minority round is...
You must be a Standard 1 Year member to access this content.
Morrison & Foerster LLP advised Walmart on the deal. Walmart Health and MeMD, a multi-specialty telehealth provider, announced they have entered into an agreement for Walmart...
You must be a Standard 1 Year member to access this content.
Greenberg Glusker Fields Claman & Machtinger LLP advised the Yogi Bhajan Administrative Trust (YBAT) on the deal. The Yogi Bhajan Administrative Trust (YBAT), co-owner of trademark...
You must be a Standard 1 Year member to access this content.
Sullivan & Worcester advised E Ink on the deal. Taylor Wessing advised Nuclera. E Ink, the leading innovator of electronic ink technology, announced the sale of its...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt LLP advised Acasti Pharma on the deal, while Reed Smith advised Grace Therapeutics. Acasti Pharma entered into of a definitive agreement to acquire Grace...
You must be a Standard 1 Year member to access this content.
Vinson & Elkins LLP advised Accelerate Real Asset Management on the deal. Accelerate Real Asset Management, a Dallas-based real asset platform, announced a $500 million joint...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aadi Bioscience on the deal while Goodwin Procter LLP represented Aerpio Pharmaceuticals, Inc. Aerpio Pharmaceuticals and Aadi Bioscience announced their...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky LLP advised Anebulo Pharmaceuticals on the deal. Anebulo Pharmaceuticals, Inc. executed its $21 million initial public offering and listing on The Nasdaq Capital Market...
You must be a Standard 1 Year member to access this content.
Olshan Frome Wolosky LLP advised Anebulo Pharmaceuticals on the deal. Anebulo Pharmaceuticals, Inc. executed its $21 million initial public offering and listing on The Nasdaq Capital Market...
You must be a Standard 1 Year member to access this content.
Cuatrecasas advised Arcline Investment Management on the deal. Arcline Investment Management (“Arcline”), a growth-oriented private equity firm with $4.3 billion of cumulative capital commitments, executed the acquisition of Polypeptide...
You must be a Standard 1 Year member to access this content.
Cassels acted for Stifel. On May 13, 2021, Aurora Solar Technologies Inc. closed a private placement of 14,200,000 units at a price of $0.25 per unit...
You must be a Standard 1 Year member to access this content.
